Back to Webinars
Harnessing the Power of Single Cell Technologies to Build More Effective Cell Therapies

Featured Speaker: Anthony E. Zamora, PhD, Assistant Professor, Medicine (Hematology and Oncology) & Microbiology & Immunology

Your data is secure. We keep your personal information safe and do not share it with any third parties. By submitting this form, you agree to receive communications from Bruker Cellular Analysis and accept our Privacy Policy. You may unsubscribe at any time.

What's Inside

In this Webinar we discuss:

Identifying key tumor- and immune-centric parameters using streamlined single cell workflows to help guide the development and validation of engineered TCR-T cells for cancer.
Single-cell analysis of bispecific CD20/CD19 CAR-T cells to identify CAR T cells with favorable anti-tumor killing potential.
A better understanding of the target specificity and biological properties of T cells that correlate with clinical outcomes is needed to help guide the development and manufacturing of highly efficacious CAR-T/TCR-T cells.
awards-bar-3-wide-color-right
awards-bar-4-wide-color-left
Watch the Webinar